These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11123903)

  • 21. Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor.
    Machleidt W; Thiele U; Laber B; Assfalg-Machleidt I; Esterl A; Wiegand G; Kos J; Turk V; Bode W
    FEBS Lett; 1989 Jan; 243(2):234-8. PubMed ID: 2917648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of the carboxy terminal part of stefin B does not have a major effect for binding to papain.
    Jerala R; Kroon-Zitko L; Kopitar M; Popovic T; Turk V
    Biomed Biochim Acta; 1991; 50(4-6):627-9. PubMed ID: 1801733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of rat salivary cystatin S variant polypeptides in Escherichia coli.
    Bedi GS; Zhou T; Bedi SK
    Arch Oral Biol; 1998 Mar; 43(3):173-82. PubMed ID: 9631169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
    Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
    Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
    Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
    Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolysis of the 85-kilodalton crystalline cysteine proteinase inhibitor from potato releases functional cystatin domains.
    Walsh TA; Strickland JA
    Plant Physiol; 1993 Dec; 103(4):1227-34. PubMed ID: 8290629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage display selection of hairpin loop soyacystatin variants that mediate high affinity inhibition of a cysteine proteinase.
    Koiwa H; D'Urzo MP; Assfalg-Machleidt I; Zhu-Salzman K; Shade RE; An H; Murdock LL; Machleidt W; Bressan RA; Hasegawa PM
    Plant J; 2001 Sep; 27(5):383-91. PubMed ID: 11576423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporary inhibition of papain by hairpin loop mutants of chicken cystatin. Distorted binding of the loops results in cleavage of the Gly(9)-Ala10 bond.
    Machleidt W; Nägler DK; Assfalg-Machleidt I; Stubbs MT; Fritz H; Auerswald EA
    FEBS Lett; 1995 Mar; 361(2-3):185-90. PubMed ID: 7698320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C.
    Olsson SL; Ek B; Björk I
    Biochim Biophys Acta; 1999 Jun; 1432(1):73-81. PubMed ID: 10366730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrophobic sequences can substitute for the wild-type N-terminal sequence of cystatin A (stefin A) in tight binding to cysteine proteinases selection of high-affinity N-terminal region variants by phage display.
    Ylinenjärvi K; Widersten M; Björk I
    Eur J Biochem; 1999 May; 261(3):682-8. PubMed ID: 10215884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C.
    Gerhartz B; Ekiel I; Abrahamson M
    Biochemistry; 1998 Dec; 37(49):17309-17. PubMed ID: 9860845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type.
    Calero M; Pawlik M; Soto C; Castaño EM; Sigurdsson EM; Kumar A; Gallo G; Frangione B; Levy E
    J Neurochem; 2001 Apr; 77(2):628-37. PubMed ID: 11299325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system.
    Tseng CC; Tseng CP; Levine MJ; Bobek LA
    Arch Biochem Biophys; 2000 Aug; 380(1):133-40. PubMed ID: 10900142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes.
    Björk I; Pol E; Raub-Segall E; Abrahamson M; Rowan AD; Mort JS
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):219-25. PubMed ID: 8166644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papain-inhibitory activity of oryzacystatin, a rice seed cysteine proteinase inhibitor, depends on the central Gln-Val-Val-Ala-Gly region conserved among cystatin superfamily members.
    Arai S; Watanabe H; Kondo H; Emori Y; Abe K
    J Biochem; 1991 Feb; 109(2):294-8. PubMed ID: 1864841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
    Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
    Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production, inhibitory activity, folding and conformational analysis of an N-terminal and an internal deletion variant of chicken cystatin.
    Auerswald EA; Nägler DK; Schulze AJ; Engh RA; Genenger G; Machleidt W; Fritz H
    Eur J Biochem; 1994 Sep; 224(2):407-15. PubMed ID: 7925354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of the highly conserved Gly-4 residue in human cystatin A.
    Shibuya K; Kaji H; Ohyama Y; Tate S; Kainosho M; Inagaki F; Samejima T
    J Biochem; 1995 Sep; 118(3):635-42. PubMed ID: 8690729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domain swapping in N-truncated human cystatin C.
    Janowski R; Abrahamson M; Grubb A; Jaskolski M
    J Mol Biol; 2004 Jul; 341(1):151-60. PubMed ID: 15312769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.